Furthermore, Horn and collaborators demonstrated that in two collagen-rich murine carcinomas, MC38 colon and EMT6 breast, the inhibition of LAIR-1 and TGF-β plus anti-PD-L1 therapy was able to control tumor growth and reshape the collagen-rich ECM (100). This evidence concerns the gene CD274 and neoplasm.